Implicit Rationing in Non-Small-Cell Lung Cancer Treatment
Author Information
Author(s): K Arndt, P Coy, J Schaafsma
Primary Institution: British Columbia Cancer Agency
Hypothesis
How are resources rationed in the treatment of non-small-cell lung cancer (NSCLC)?
Conclusion
The study found that treatment resources for NSCLC are implicitly rationed based on medical considerations, patient age, and smoker status.
Supporting Evidence
- An increase in age from 50 to 85 reduces expected treatment expenditure by 50-70%.
- Patients with a Karnofsky performance status (KPS) less than 80 receive significantly less treatment expenditure.
- Active smokers receive about 71-86% of the treatment expenditure compared to non-smokers.
Takeaway
Doctors sometimes give less treatment to older patients and smokers, even if they could benefit from more care.
Methodology
An ordered logit model was used to analyze the relationship between treatment selection and various patient factors.
Potential Biases
Implicit biases may exist regarding age and smoking status affecting treatment decisions.
Limitations
The study does not include follow-up costs after primary treatment.
Participant Demographics
Patients ranged in age from 48 to 89 years, with a mean age of 70; 40.6% were active smokers.
Statistical Information
P-Value
p<0.00001
Statistical Significance
p<0.00001
Want to read the original?
Access the complete publication on the publisher's website